MX344751B - Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos. - Google Patents
Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos.Info
- Publication number
- MX344751B MX344751B MX2014002449A MX2014002449A MX344751B MX 344751 B MX344751 B MX 344751B MX 2014002449 A MX2014002449 A MX 2014002449A MX 2014002449 A MX2014002449 A MX 2014002449A MX 344751 B MX344751 B MX 344751B
- Authority
- MX
- Mexico
- Prior art keywords
- capsid protein
- papilloma virus
- human papilloma
- major capsid
- genes encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/18011—Nimaviridae
- C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención se refiere a un gen aislado que codifica la proteína L1 mayor de cápside del virus de papiloma humano, caracterizado porque dicho gen tiene condones preferidos por la levadura Pichia, y en donde dicho gen codifica la proteína L1 mayor de cápside del virus del papiloma humano y tiene una secuencia de nucleótidos seleccionada de aquellas expuestas en SEQ ID NO: 7, SEQ ID NO: 8 y SEQ ID NO: 9.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710170935 CN101440372B (zh) | 2007-11-23 | 2007-11-23 | 一种18型人乳头状瘤病毒主要衣壳蛋白l1基因 |
CN200710170934A CN101440371B (zh) | 2007-11-23 | 2007-11-23 | 一种16型人乳头状瘤病毒主要衣壳蛋白l1基因 |
CN200710170936A CN101440373B (zh) | 2007-11-23 | 2007-11-23 | 一种截短型的18型人乳头状瘤病毒主要衣壳蛋白l1基因 |
CN200810032655A CN101487010B (zh) | 2008-01-15 | 2008-01-15 | 用毕赤酵母表达系统制备抗人乳头瘤病毒18型感染的疫苗的方法 |
CN2008100326547A CN101487009B (zh) | 2008-01-15 | 2008-01-15 | 用毕赤酵母表达系统制备抗人乳头瘤病毒16型感染的疫苗的方法 |
PCT/CN2008/073167 WO2009076824A1 (zh) | 2007-11-23 | 2008-11-24 | 人乳头状瘤病毒主要衣壳蛋白l1基因及其用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX344751B true MX344751B (es) | 2017-01-05 |
Family
ID=40795163
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010005699A MX2010005699A (es) | 2007-11-23 | 2008-11-24 | Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos. |
MX2014002449A MX344751B (es) | 2007-11-23 | 2008-11-24 | Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010005699A MX2010005699A (es) | 2007-11-23 | 2008-11-24 | Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos. |
Country Status (9)
Country | Link |
---|---|
US (2) | US8795676B2 (es) |
EP (3) | EP2479187A1 (es) |
KR (1) | KR101588413B1 (es) |
CN (1) | CN101835797A (es) |
BR (1) | BRPI0818957B8 (es) |
MX (2) | MX2010005699A (es) |
MY (2) | MY162658A (es) |
RU (1) | RU2494106C2 (es) |
WO (1) | WO2009076824A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110699366B (zh) * | 2013-12-26 | 2022-11-25 | 上海泽润生物科技有限公司 | 重组人乳头瘤病毒6和11亚型蛋白毕赤酵母表达 |
CN117187262A (zh) * | 2014-02-18 | 2023-12-08 | 上海泽润生物科技有限公司 | 重组人乳头瘤病毒蛋白表达 |
JP2017528137A (ja) * | 2014-09-11 | 2017-09-28 | カディラ ヘルスケア リミティド | 卓越した免疫学的特性を有する卓越したヒトパピローマウイルス抗原及びそれを含むワクチン |
CN106893730B (zh) * | 2015-12-18 | 2021-06-11 | 上海泽润生物科技有限公司 | 重组人乳头瘤蛋白表达 |
JOP20190242A1 (ar) * | 2018-10-12 | 2020-04-12 | Serum Institute Of India Pvt Ltd | تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0595935T3 (da) * | 1991-07-19 | 2003-07-21 | Csl Ltd | Papillomavirusvaccine |
AU693511B2 (en) * | 1994-02-07 | 1998-07-02 | Qiagen Gmbh | Endotoxin reduction or removal process |
HUT76354A (en) * | 1994-05-16 | 1997-08-28 | Merck & Co Inc | Papillomavirus vaccines |
WO1996011272A2 (de) * | 1994-10-07 | 1996-04-18 | Medigene Gesellschaft Für Molekularbiologische Diagnostik, Theraphie Und Technologie Mbh | Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung |
US6436402B1 (en) * | 1999-10-15 | 2002-08-20 | Merck & Co., Inc. | Process for making human papillomavirus virus-like particles with improved properties |
DE10055545A1 (de) * | 2000-11-09 | 2002-07-25 | Deutsches Krebsforsch | Für Expression in Eukaryonten optimierte HPV 16-L1 und HPV 16-L2 kodierende DNA Sequenzen |
KR101080628B1 (ko) * | 2003-03-24 | 2011-11-08 | 머크 샤프 앤드 돔 코포레이션 | 효모에서 hpv 31 l1의 최적 발현 |
MY140664A (en) * | 2003-09-29 | 2010-01-15 | Merck Sharp & Dohme | Optimized expression of hpv 45 l1 in yeast |
MY139500A (en) * | 2003-11-12 | 2009-10-30 | Merck Sharp & Dohme | Optimized expression of hpv 58 l1 in yeast |
PL1730175T3 (pl) * | 2004-03-24 | 2010-09-30 | Merck Sharp & Dohme | Optymalizowana ekspresja L1 HPV 52 w drożdżach |
-
2008
- 2008-11-24 EP EP12163173A patent/EP2479187A1/en not_active Withdrawn
- 2008-11-24 EP EP12163171.7A patent/EP2479186B1/en active Active
- 2008-11-24 KR KR1020107013012A patent/KR101588413B1/ko active IP Right Grant
- 2008-11-24 MY MYPI2010002378A patent/MY162658A/en unknown
- 2008-11-24 MY MYPI2014003456A patent/MY182347A/en unknown
- 2008-11-24 WO PCT/CN2008/073167 patent/WO2009076824A1/zh active Application Filing
- 2008-11-24 BR BRPI0818957A patent/BRPI0818957B8/pt active IP Right Grant
- 2008-11-24 US US12/744,190 patent/US8795676B2/en active Active
- 2008-11-24 MX MX2010005699A patent/MX2010005699A/es active IP Right Grant
- 2008-11-24 MX MX2014002449A patent/MX344751B/es unknown
- 2008-11-24 RU RU2010125695/10A patent/RU2494106C2/ru active
- 2008-11-24 EP EP08860834.4A patent/EP2223933B1/en active Active
- 2008-11-24 CN CN200880113582A patent/CN101835797A/zh active Pending
-
2014
- 2014-06-05 US US14/296,700 patent/US9034340B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2479186A1 (en) | 2012-07-25 |
CN101835797A (zh) | 2010-09-15 |
EP2479186B1 (en) | 2015-08-12 |
BRPI0818957B1 (pt) | 2021-05-04 |
MY182347A (en) | 2021-01-20 |
RU2494106C2 (ru) | 2013-09-27 |
MY162658A (en) | 2017-06-30 |
WO2009076824A1 (zh) | 2009-06-25 |
US9034340B2 (en) | 2015-05-19 |
EP2223933B1 (en) | 2016-01-27 |
KR20100102114A (ko) | 2010-09-20 |
KR101588413B1 (ko) | 2016-02-02 |
EP2223933A4 (en) | 2012-01-04 |
US20110256182A1 (en) | 2011-10-20 |
US20140328935A1 (en) | 2014-11-06 |
US8795676B2 (en) | 2014-08-05 |
EP2479187A1 (en) | 2012-07-25 |
MX2010005699A (es) | 2010-09-14 |
RU2010125695A (ru) | 2011-12-27 |
BRPI0818957B8 (pt) | 2021-05-25 |
BRPI0818957A2 (pt) | 2019-12-17 |
EP2223933A1 (en) | 2010-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010005699A (es) | Genes que codifican para la proteina l1 mayor de la capside del virus del papiloma humano y uso de los mismos. | |
EP3444352A3 (en) | Production of recombinant vaccine in e. coli by enzymatic conjugation | |
EA201190327A1 (ru) | Новые конструкции белка вируса папилломы человека (hpv) и их применение в предупреждении заболевания, вызываемого hpv | |
WO2006060314A3 (en) | Generation of replication competent viruses for therapeutic use | |
WO2011150133A3 (en) | Fibronectin based scaffold proteins having improved stability | |
WO2008034388A8 (fr) | Particules virales de protéines de la capside provenant du papillomavirus humain de type 16/58/18/6/11 et leur procédé de préparation et leurs utilisations | |
EP2388270A3 (en) | Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor | |
MY140664A (en) | Optimized expression of hpv 45 l1 in yeast | |
MX2010003713A (es) | Vacunas de citomegalovirus y metodos de produccion. | |
WO2011142865A3 (en) | Yeast microorganisms with reduced by-product accumulation for improved production of fuels, chemicals, and amino acids | |
WO2008118392A3 (en) | Synthetic cell platforms and methods of use thereof | |
WO2009020144A1 (ja) | 異種タンパク質の製造方法 | |
WO2009099877A3 (en) | Closterovirus vectors and methods | |
NZ611531A (en) | Bovine viral diarrhea virus type 1b vaccine compositions and methods | |
WO2004067760A3 (en) | Xylose-fermenting recombinant yeast strains | |
WO2010079991A3 (ko) | 안정적인 항시적 고발현 자궁경부암 치료백신용 벡터 및 그에 의해 형질전환된 재조합 유산균 | |
ZA200900164B (en) | Cysteine granules and use thereof as bifidobacterium animals lactis growth stimulants | |
WO2023141602A3 (en) | Engineered retrons and methods of use | |
BRPI0518109A (pt) | cepa bacteriana, nucleocapsìdeo, preparação de vacina, método para criar uma bactéria recombinante, bactéria mutante, seqüências de rna fluorado para deslanchar rdsrna e meio para eletroporação | |
NZ599479A (en) | Improved reverse genetics methods for virus rescue | |
NZ578959A (en) | Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) | |
CL2008003821A1 (es) | Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado | |
WO2009088950A3 (en) | Pcv2 orf2 virus like particle with foreign amino acid insertion | |
BR0105162A (pt) | Cepa de leveduras metilotróficas recombinantes produtoras de um precursor de insulina, construções do dna e método para a obtenção da cepa | |
WO2010111586A3 (en) | Mucosal immunization |